Over 1,200 biotherapeutics industry experts will convene at this annual event to share insight and perspective on the evolution of biologics, and the generation, characterization, and clinical application of proteins.

Discussions will include a variety of issues on how to expedite your biologic to the market safely by overcoming immunogenicity assessment challenges, adopting prediction and mitigation approaches, and selecting the right bioassay.

Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accelerate the healing of injured tissues, is pleased to announce that it has been awarded a Phase I Small Business Innovation Research...

SMi Group Reports: representatives over 55 companies will meet in Iselin, NJ, to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

Ten fellowship award winners will receive a poster presentation slot and a discounted registration rate of $195.* Full-time graduate students and Ph.D. candidates should apply. The summit will take place on May 5-7, 2014 in Boston, MA.

SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.

Dr. Lathey sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, tools and strategies that researchers are using to combat it, and how procedural variation can have unwanted effects.

Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...

Over 1,200 biotherapeutics industry experts will convene at this annual event to share insight and perspective on the evolution of biologics, and the generation, characterization, and clinical application of proteins.

Discussions will include a variety of issues on how to expedite your biologic to the market safely by overcoming immunogenicity assessment challenges, adopting prediction and mitigation approaches, and selecting the right bioassay.

Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accelerate the healing of injured tissues, is pleased to announce that it has been awarded a Phase I Small Business Innovation Research...

SMi Group Reports: representatives over 55 companies will meet in Iselin, NJ, to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

Ten fellowship award winners will receive a poster presentation slot and a discounted registration rate of $195.* Full-time graduate students and Ph.D. candidates should apply. The summit will take place on May 5-7, 2014 in Boston, MA.

SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.

Dr. Lathey sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, tools and strategies that researchers are using to combat it, and how procedural variation can have unwanted effects.

Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...

Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer. TriConference.com

Those that missed last month's event can get a CD with 80 speaker presentations from 4 pipelines: formulation, purification, biotherapeutics, and expression. Individual track CDs and the overall event CD is available at CHI-PepTalk.com.

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

A new global market report on 'Orthopedic Implants' has been released by Industry Experts. According to the report, the global market for orthopedic implants is projected to reach US$ 46.5 billion by 2017 from an estimated US$ 21.1 billion in 2007.

Harrisburg University will host a panel “Biologics and Biosimilars” that will bring together key PA-based stakeholders—patient groups, physicians, opinion leaders and the bioscience community—to facilitate a policy discussion on biosimilars.

French and American governments have implemented 2009-2011 tax incentives for drug developers or manufacturers, which bode well for the biopharmaceutical market worldwide, according to healthcare market research firm Kalorama Information in its...

We are less than two months away from a must attend educational and networking event for scientific and business leaders involved in drug delivery and formulation to discuss the current challenges and new strategies to succeed in this evolving area.